Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Evans Syndrome is a rare, chronic hematological condition characterized by the simultaneous or sequential development of autoimmune hemolytic anemia and immune thrombocytopenia. Because it is often secondary to other underlying diseases, its exact prevalence remains unknown, but it is classified as a rare disease with a highly variable presentation across all age groups. Is Evans Syndrome considered a rare disease? Yes, Evans Syndrome is definitively classified as a rare disease.
TL;DR: Evans Syndrome is a rare, chronic hematological condition characterized by the simultaneous or sequential development of autoimmune hemolytic anemia and immune thrombocytopenia. Because it is often secondary to other underlying diseases, its exact prevalence remains unknown, but it is classified as a rare disease with a highly variable presentation across all age groups.
Yes, Evans Syndrome is definitively classified as a rare disease. Because it frequently occurs as a manifestation of underlying autoimmune disorders, such as Systemic Lupus Erythematosus (SLE) or Common Variable Immunodeficiency (CVID), it is difficult to isolate exact epidemiological data. Current medical literature indicates that Evans Syndrome is significantly underdiagnosed, as many patients are initially treated for isolated cytopenias before the dual-diagnosis is confirmed. At DiseaseMaps.org, we have seen 110 people with Evans Syndrome join our community, reflecting the global reach of this rare condition and the need for patient-led data collection.
There are no precise global prevalence or incidence figures for Evans Syndrome in the general population. While some smaller, localized studies suggest a rare occurrence, the lack of a centralized global registry makes definitive statistical modeling impossible. The challenge in quantifying Evans Syndrome lies in its heterogeneous nature; it is often a "moving target" that changes as the patient’s primary immune profile evolves. Most clinical experts view Evans Syndrome as a clinical diagnosis rather than a distinct disease entity, which further complicates efforts to track new cases annually.
Evans Syndrome can affect individuals of any age, from early childhood to late adulthood. Clinical observations suggest the following patterns regarding its distribution:
Accurate prevalence data for Evans Syndrome is hindered by three primary factors: misdiagnosis, underdiagnosis, and the overlap with primary immune deficiencies. Patients often present with symptoms of anemia or low platelets long before the full criteria for Evans Syndrome are met. Furthermore, because it is often secondary to other conditions, it may be coded in hospital records under the primary disease (such as lymphoma or autoimmune lymphoproliferative syndrome) rather than as Evans Syndrome itself. This is why community-led platforms like DiseaseMaps.org are vital; they provide a real-world perspective that clinical trials and hospital databases often miss.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.